The EU funds research into psychedelic-based therapies for psychological distress in incurable disease patients.

The European Union is funding research into psychedelic-based therapies to alleviate psychological distress in patients with incurable diseases. Researchers will explore the use of psychedelic drugs such as psilocybin to aid palliative care patients, for whom there are limited options. This EU investment in innovative treatment options reflects widespread interest in exploring alternative therapies for those facing terminal illnesses.

January 29, 2024
6 Articles

Further Reading